UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefits and limitations of humanized mice in HIV persistence studies

Retrovirology, 2020-04, Vol.17 (1), p.7-7, Article 7

Marsden, Matthew D

2020

Volltextzugriff (PDF)

Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol

Immunity (Cambridge, Mass.), 2013-01, Vol.38 (1), p.92-105

2013

Volltextzugriff (PDF)

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

Nature communications, 2022-01, Vol.13 (1), p.121-14, Article 121

2022

Volltextzugriff (PDF)

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

Viruses, 2024-07, Vol.16 (7), p.1163

2024

Volltextzugriff (PDF)

Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches

Frontiers in immunology, 2022-05, Vol.13, p.905773

2022

Volltextzugriff (PDF)

In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication

PLoS pathogens, 2017-09, Vol.13 (9), p.e1006575-e1006575

2017

Volltextzugriff (PDF)

Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo

Proceedings of the National Academy of Sciences - PNAS, 2013-07, Vol.110 (29), p.11698-11703

2013

Volltextzugriff (PDF)

Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window

Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (20), p.10688-10698

2020

Volltextzugriff (PDF)

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

Nature communications, 2020-04, Vol.11 (1), p.1879-1879, Article 1879

2020

Volltextzugriff (PDF)

Activation of latent HIV using drug-loaded nanoparticles

PloS one, 2011-04, Vol.6 (4), p.e18270

2011

Volltextzugriff (PDF)

HIV Latency in the Humanized BLT Mouse

Journal of Virology, 2012-01, Vol.86 (1), p.339-347

2012

Volltextzugriff (PDF)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

Virology (New York, N.Y.), 2018-07, Vol.520, p.83-93

2018

Volltextzugriff (PDF)

Double Trouble: HIV Latency and CTL Escape

Cell host & microbe, 2015-02, Vol.17 (2), p.141-142

2015

Volltextzugriff (PDF)

Neutralizing the HIV Reservoir

Cell, 2014-08, Vol.158 (5), p.971-972

2014

Volltextzugriff (PDF)

Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

Cell reports. Medicine, 2020-06, Vol.1 (3), p.100037-100037, Article 100037

2020

Volltextzugriff (PDF)

HIV establishes an early foothold

Cell host & microbe, 2023-04, Vol.31 (4), p.571-573

2023

Volltextzugriff (PDF)

Disruption of Type I Interferon Induction by HIV Infection of T Cells

PloS one, 2015-09, Vol.10 (9), p.e0137951-e0137951

2015

Volltextzugriff (PDF)

Studies of retroviral infection in humanized mice

Virology (New York, N.Y.), 2015-05, Vol.479, p.297-309

2015

Volltextzugriff (PDF)

Single Mutations in HIV Integrase Confer High-Level Resistance to Raltegravir in Primary Human Macrophages

Antimicrobial Agents and Chemotherapy, 2011-08, Vol.55 (8), p.3696-3702

2011

Volltextzugriff (PDF)

Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro

Nature chemistry, 2012-09, Vol.4 (9), p.705-710

2012

Volltextzugriff (PDF)

Humanized Mouse Models for Human Immunodeficiency Virus Infection

Annual review of virology, 2017-09, Vol.4 (1), p.393-412

2017

Volltextzugriff (PDF)

RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice

Molecular therapy. Nucleic acids, 2015-02, Vol.4 (2), p.e227-e227, Article e227

2015

Volltextzugriff (PDF)

Can macrophages form a latent reservoir of HIV?

Future virology, 2021-02, Vol.16 (2), p.75-77

2021

Volltextzugriff (PDF)

Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal

Virology (New York, N.Y.), 2023-04, Vol.581, p.8-14

2023

Volltextzugriff (PDF)

Human Immunodeficiency Virus Bearing a Disrupted Central DNA Flap Is Pathogenic In Vivo

Journal of Virology, 2007-06, Vol.81 (11), p.6146-6150

2007

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(100)

Sprache

Englisch
(100)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(38)
Humans
(37)
Physical Sciences
(25)
Hiv
(23)
Animals
(21)
Human Immunodeficiency Virus
(21)
Astronomy
(20)
Astronomy & Astrophysics
(20)
Astrophysics
(20)
Earth, Ocean, Space
(20)
Exact Sciences And Technology
(20)
Physics
(20)
Virology
(20)
Latency
(18)
Astrophysics, Cosmology And Astronomy
(17)
Mice
(14)
Explosions
(13)
Telescopes
(13)
Balloons
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Benefits and limitations of humanized mice in HIV persistence studies

Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches

In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication

Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo

Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

Activation of latent HIV using drug-loaded nanoparticles

HIV Latency in the Humanized BLT Mouse

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

Double Trouble: HIV Latency and CTL Escape

Neutralizing the HIV Reservoir

Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

HIV establishes an early foothold

Disruption of Type I Interferon Induction by HIV Infection of T Cells

Studies of retroviral infection in humanized mice

Single Mutations in HIV Integrase Confer High-Level Resistance to Raltegravir in Primary Human Macrophages

Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro

Humanized Mouse Models for Human Immunodeficiency Virus Infection

RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice

Can macrophages form a latent reservoir of HIV?

Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal

Human Immunodeficiency Virus Bearing a Disrupted Central DNA Flap Is Pathogenic In Vivo

Suchergebnisse filtern